Human papillomavirus infection and p53 protein expression in vulvar intraepithelial neoplasia and invasive squamous cell carcinoma

Brazilian Journal of Medical and Biological Research

Volumn 36, Issue 9, 2003, Pages 1159-1165

  Engelman, Diana E S ^a,b   Andrade, L A L A ^a   Vassallo, J ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b NONE   (Brazil)

Author keywords

Human papillomavirus; p53 protein; Vulvar carcinoma; Vulvar intraepithelial neoplasia

Indexed keywords

PARAFFIN; PROTEIN P53;

ADULT; AGE DISTRIBUTION; ARTICLE; BASAL CELL CARCINOMA; CANCER INVASION; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPOTHESIS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MAJOR CLINICAL STUDY; PROTEIN ANALYSIS; PROTEIN EXPRESSION; RETROSPECTIVE STUDY; SQUAMOUS CELL CARCINOMA; TUMOR LOCALIZATION; UTERINE CERVIX CARCINOMA IN SITU; VIRUS DETECTION; VIRUS INFECTION; VIRUS PATHOGENESIS; VULVA CARCINOMA; WART VIRUS;

DNA VIRUSES; HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPES; PAPILLOMAVIRUS;

EID: 0141920446     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/S0100-879X2003000900003     Document Type: Article

References (26)

1. Costa S, Syrjänen S, Vendra C, Chang F, Guida G, Hippeläinen M, Terzano, P, Tervahauta A, Yliskoski M & Syrjänen K (1995). Human papillomavirus infections in vulvar precancerous lesions and cancer. Journal of Reproductive Medicine, 40: 291-298.
2. Kagie MJ, Kenter GG, Tollenaar RAEM, Hermans J, Trimbos JB & Fleuren GJ (1997). P53 protein overexpression is independent of human papillomavirus infection in squamous cell carcinoma of the vulva. Cancer, 80: 1228-1233.
3. Thomas M, Pim D & Banks L (1999). The role of the E6-p53 interaction in the molecular pathogenesis of HPV. Oncogene, 18: 7690-7700.
4. Stoler MH (2000). Human papillomaviruses and cervical neoplasia: a model for carcinogenesis. International Journal of Gynecological Pathology, 19: 16-28.
5. Lee YY, Wilczynski SP, Chumakov A, Chih D & Koffler UP (1994). Carcinoma of the vulva: HPV and p53 mutations. Oncogene, 9: 1655-1659.
6. Pilotti S, D'Amato L, Della Torre G, Donghi R, Langoni A, Giarola M, Sampietro G, De Palo G, Pierotti MA & Rilke F (1995). Papillomavirus, p53 alteration, and primary carcinoma of the vulva. Diagnostic Molecular Pathology, 4: 239-248.
7. Velculescu VE & El-Deiry WS (1996). Biological and clinical importance of the p53 tumor suppressor gene. Clinical Chemistry, 42: 858-868.
8. Hørding U, Junge J, Daugaard S, Lundvall F, Poulsen H & Bock JE (1994). Vulvar squamous cell carcinoma and papillomaviruses: indications for two different etiologies. Gynecologic Oncology, 52: 241-246.
9. Trimble CL, Hildensheim A, Brinton LA, Shah KV & Kurman RJ (1996). Heterogeneous etiology of squamous carcinoma of the vulva. Obstetrics and Gynecology, 87: 59-64.
10. ACOG Technical Bulletin (1994). Vulvar cancer. International Journal of Gynecology and Obstetrics, 44: 79-86.
11. Andersen WA, Franquemont DW, Williams J, Taylor PT & Crum CP (1991). Vulvar squannous cell carcinoma and papillomaviruses: two separate entities? American Journal of Obstetrics and Gynecology, 165: 329-336.
12. Pinto AP, Lin MC, Mutter GL, Sun D, Villa LL & Crum CP (1999). Allelic loss in human papillomavirus-positive and -negative vulvar squamous cell carcinomas. American Journal of Pathology, 154: 1009-1015.
13. Carlson JA, Amin S, Malfetano J et al. (2001). Concordant p53 and mdm-2 protein expression in vulvar squamous cell carcinoma and adjacent lichen sclerosus. Applied Immunohistochemistry and Molecular Morphology, 9: 150-163.
14. Yang B & Hart WR (2000). Vulvar intraepithelial neoplasia of the simplex (differentiated) type. American Journal of Surgical Pathology, 24: 429-441.
15. Hietanen S, Grénman S, Syrjänen K, Lappalainen K, Kauppinen J, Carey T & Syrjänen S (1995). Human papillomavirus in vulvar and vaginal carcinoma cell lines. British Journal of Cancer, 72: 134-139.
16. Kohlberger PD, Kirnbauer R, Bancher D, Gitsch G, Reinthaller A, Leodolter S, Tschachler E, Kainz C & Breitenecker G (1998). Absence of p53 protein overexpression in precancerous lesions of the vulva. Cancer, 82: 323-327.
17. Kim JW, Cho YH, Lee CG, Kim JH, Kim HK, Kim EJ, Han KT & Namkoong SE (1997). Human papillomavirus infection and TP53 gene mutation in primary cervical carcinoma. Acta Oncologica, 36: 295-300.
18. Tervahauta AI, Syriänen SM, Väyrynen M, Saastamoinen J & Syrjäne KJ (1993). Expression of p53 protein related to the presence of human papillomavirus (HPV) DNA in genital carcinomas and precancer lesions. Anticancer Research, 13: 1107-1111.
19. Benedet JL, Bender H, Jones 3rd H, Ngan HY & Pecorelli S (2000). FIGO staging classifications and clinical practice guidelines in the management of gynecologic cancers. FIGO Committee on Gynecologic Oncology. International Journal of Gynecology and Obstetrics, 70: 209-262.
20. Vassallo J, Derchain SF, Pinto GA, Martinez EZ, Syrjänen KJ & Andrade LA (2000). High risk HPV and p53 protein expression in cervical intraepithelial neoplasia. International Journal of Gynecology and Obstetrics, 71: 45-48.
21. Edwards CL, Tortolero-Luna G, Linares AC, Malpica A, Baker W, Cook E, Johnson E & Mitchell MF (1996). Vulvar intraepithelial neoplasia and vulvar cancer. Obstetrics and Gynecology Clinics of North America, 23: 295-324.
22. Herod JJO, Shafi MI, Rollason TP, Jordan JA & Luesley DM (1996). Vulvar intraepithelial neoplasia with superficially invasive carcinoma of the vulva. British Journal of Obstetrics and Gynaecology, 103: 453-456.
23. Chetty R, Bramdev A, Aguirre-Arteta A, Pegoraro RJ & Sataar N (1997). Relation between retinoblastoma and p53 proteins in human papilloma viruses 16/18 positive and negative cancers of the uterine cervix. Journal of Clinical Pathology, 50: 413-416.
24. Junge J, Poulsen H, Horn T, Hørding U & Lundvall F (1997). Prognosis of vulvar dysplasia and carcinoma in situ with special reference to histology and types of human papillomavirus (HPV). Acta Pathologica, Microbiologica at Immunologica Scandinavica, 105: 963-971.
25. Kagie MJ, Kenter GG, Tollenaar RAEM, Hermans J, Trimbos JB & Fleuren GJ (1997). P53 protein overexpression, a frequent observation in squamous cell carcinoma of the vulva and in various synchronous vulvar epithelia, has no value as a prognostic parameter. International Journal of Gynecological Pathology, 16: 124-130.
26. McConnell DT, Miller ID, Parkin DE & Murray GI (1997). P53 protein expression in a population-based series of primary vulval squamous cell carcinoma and immediate adjacent field change. Gynecologic Oncology, 67: 248-254.